Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 30th, there was short interest totaling 26,122 shares, an increase of 183.5% from the October 15th total of 9,213 shares. Based on an average trading volume of 1,273 shares, the days-to-cover ratio is presently 20.5 days.
Shin Nippon Biomedical Laboratories Stock Performance
OTCMKTS SBLOF remained flat at $9.60 on Friday. Shin Nippon Biomedical Laboratories has a 12 month low of $7.00 and a 12 month high of $10.00. The company’s fifty day simple moving average is $7.68 and its 200-day simple moving average is $8.31.
Shin Nippon Biomedical Laboratories Company Profile
Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a Japan-based contract research organization that supports pharmaceutical and biotechnology companies in developing medicines and other healthcare products. Founded in 1957, the company provides research and development services spanning nonclinical studies and clinical research. Its nonclinical services include safety and toxicity testing, pharmacology, and other studies used to evaluate drug candidates before human trials. SNBL also provides clinical trial and clinical pharmacology services, helping clients plan and conduct studies involving human participants.
Featured Stories
- Five stocks we like better than Shin Nippon Biomedical Laboratories
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Shin Nippon Biomedical Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shin Nippon Biomedical Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
